Price to Earning ratio Analysis of Ambrx Biopharma Inc ADR - Deep Dive
Latest FY PE
Period Ending - Dec-23
Very Poor PE
Period Ending - Dec-22
Very Poor PE
-97.01
Growth
%
Trailing Twelve Months PE
Period Ending - Dec-23
Very Poor PE
-16463.91
PE Analysis of Ambrx Biopharma Inc ADR
P/E Ratio -16463.91 of Ambrx Biopharma Inc ADR is negative because of negative EPS. |
PE Ratio of AMAM rose handsomely by % this year. |
PE Ratio with value of was highest in Year Dec-23 in last Five Years. |
PE Ratio with value of -97.01 was lowest in Year Dec-22 in last Five Years. |
Latest PE Ratio with value of is lower than Average PE of in last five years. |
Other PE Related Info of AMAM that may interest you.
Ambrx Biopharma Inc ADR Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
AMAM | 28.0 | 27.98 | 0.071 % | Biotechnology |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..PE Related Ratios
PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Earning of Ambrx Biopharma Inc ADR
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
---|---|---|---|---|---|
PE | -97.01 | -8.41 | -63.76 | -52.57 | |
Change | % | -1053.25 % | 86.81 % | -21.27 % |
FY Chart of Price to Earning of Ambrx Biopharma Inc ADR
Note : All Data Generated at the End of Trading Hours (EOD Data)